Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 197

1.

Ursolic acid ameliorates thymic atrophy and hyperglycemia in streptozotocin-nicotinamide-induced diabetic mice.

Lee J, Yee ST, Kim JJ, Choi MS, Kwon EY, Seo KI, Lee MK.

Chem Biol Interact. 2010 Dec 5;188(3):635-42. doi: 10.1016/j.cbi.2010.09.019.

PMID:
20869956
2.

Ursolic acid enhances the cellular immune system and pancreatic beta-cell function in streptozotocin-induced diabetic mice fed a high-fat diet.

Jang SM, Yee ST, Choi J, Choi MS, Do GM, Jeon SM, Yeo J, Kim MJ, Seo KI, Lee MK.

Int Immunopharmacol. 2009 Jan;9(1):113-9. doi: 10.1016/j.intimp.2008.10.013.

PMID:
19013541
3.

Reduction of oxidative stress by a new low-molecular-weight antioxidant improves metabolic alterations in a nonobese mouse diabetes model.

Novelli M, D'Aleo V, Lupi R, Paolini M, Soleti A, Marchetti P, Masiello P.

Pancreas. 2007 Nov;35(4):e10-7.

PMID:
18090226
4.

Inhibitory effects of ursolic acid on hepatic polyol pathway and glucose production in streptozotocin-induced diabetic mice.

Jang SM, Kim MJ, Choi MS, Kwon EY, Lee MK.

Metabolism. 2010 Apr;59(4):512-9. doi: 10.1016/j.metabol.2009.07.040.

PMID:
19846180
5.

Effects of antidiabetic drugs on glucose tolerance in streptozotocin-nicotinamide-induced mildly diabetic and streptozotocin-induced severely diabetic mice.

Tahara A, Matsuyama-Yokono A, Nakano R, Someya Y, Shibasaki M.

Horm Metab Res. 2008 Dec;40(12):880-6. doi: 10.1055/s-0028-1087167.

PMID:
18819058
7.

Establishment and pathophysiological characterization of type 2 diabetic mouse model produced by streptozotocin and nicotinamide.

Nakamura T, Terajima T, Ogata T, Ueno K, Hashimoto N, Ono K, Yano S.

Biol Pharm Bull. 2006 Jun;29(6):1167-74.

8.

Anti-hyperglycemic, antioxidant and anti-inflammatory effects of VIP and a VPAC1 agonist on streptozotocin-induced diabetic mice.

Yu R, Zhang H, Huang L, Liu X, Chen J.

Peptides. 2011 Feb;32(2):216-22. doi: 10.1016/j.peptides.2010.11.017.

PMID:
21129425
9.

Effects of ursolic acid on glucose metabolism, the polyol pathway and dyslipidemia in non-obese type 2 diabetic mice.

Lee J, Lee HI, Seo KI, Cho HW, Kim MJ, Park EM, Lee MK.

Indian J Exp Biol. 2014 Jul;52(7):683-91.

PMID:
25059036
10.

The association of acetyl-l-carnitine and nicotinamide remits the experimental diabetes in mice by multiple low-dose streptozotocin.

Cresto JC, Fabiano de Bruno LE, Cao GF, Pastorale CF, Confalonieri N, del Carmen Camberos M, Basabe JC.

Pancreas. 2006 Nov;33(4):403-11.

PMID:
17079947
11.
12.

Oral L-glutamine increases active GLP-1 (7-36) amide secretion and improves glycemic control in stretpozotocin-nicotinamide induced diabetic rats.

Badole SL, Bagul PP, Mahamuni SP, Khose RD, Joshi AC, Jangam GB, Ghule AE, Raut CG, Khedkar VM, Coutinho EC.

Chem Biol Interact. 2013 Apr 25;203(2):530-41. doi: 10.1016/j.cbi.2013.02.006.

PMID:
23466488
13.
14.

Combination of TS-021 with metformin improves hyperglycemia and synergistically increases pancreatic β-cell mass in a mouse model of type 2 diabetes.

Tajima A, Hirata T, Taniguchi K, Kondo Y, Kato S, Saito-Hori M, Ishimoto T, Yamamoto K.

Life Sci. 2011 Oct 24;89(17-18):662-70. doi: 10.1016/j.lfs.2011.08.005.

PMID:
21872612
15.

Cycloart-23-ene-3β, 25-diol stimulates GLP-1 (7-36) amide secretion in streptozotocin-nicotinamide induced diabetic Sprague Dawley rats: a mechanistic approach.

Badole SL, Mahamuni SP, Bagul PP, Khose RD, Joshi AC, Ghule AE, Bodhankar SL, Raut CG, Khedkar VM, Coutinho EC, Wagh NK.

Eur J Pharmacol. 2013 Jan 5;698(1-3):470-9. doi: 10.1016/j.ejphar.2012.10.002.

PMID:
23117087
16.

Effects of the combination of dipeptidyl peptidase-IV inhibitor ASP8497 and antidiabetic drugs in streptozotocin-nicotinamide-induced mildly diabetic mice.

Tahara A, Matsuyama-Yokono A, Nakano R, Someya Y, Hayakawa M, Shibasaki M.

Eur J Pharmacol. 2009 Mar 1;605(1-3):170-6. doi: 10.1016/j.ejphar.2008.12.040.

PMID:
19171131
17.

Lipid peroxidation in nicotinamide-deficient and nicotinamide-supplemented rats with streptozotocin-induced diabetes.

Melo SS, Arantes MR, Meirelles MS, Jordão AA Jr, Vannucchi H.

Acta Diabetol. 2000 Mar;37(1):33-9.

PMID:
10928234
19.
20.

Antihyperglycemic effect of diosmin on hepatic key enzymes of carbohydrate metabolism in streptozotocin-nicotinamide-induced diabetic rats.

Pari L, Srinivasan S.

Biomed Pharmacother. 2010 Sep;64(7):477-81. doi: 10.1016/j.biopha.2010.02.001.

PMID:
20362409
Items per page

Supplemental Content

Support Center